| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Coronary Artery Bypass | 19 | 2024 | 516 | 5.080 |
Why?
|
| Heart Valve Prosthesis Implantation | 19 | 2023 | 437 | 4.950 |
Why?
|
| Cardiac Surgical Procedures | 24 | 2023 | 1123 | 4.080 |
Why?
|
| Aortic Valve | 14 | 2023 | 445 | 2.820 |
Why?
|
| Heart Valve Prosthesis | 9 | 2022 | 302 | 2.750 |
Why?
|
| Patient Readmission | 10 | 2024 | 385 | 2.520 |
Why?
|
| Myocardial Infarction | 7 | 2022 | 1043 | 2.480 |
Why?
|
| Bioprosthesis | 3 | 2023 | 111 | 1.760 |
Why?
|
| Postoperative Complications | 19 | 2024 | 3056 | 1.680 |
Why?
|
| Mitral Valve | 11 | 2022 | 252 | 1.670 |
Why?
|
| Coronary Artery Disease | 8 | 2024 | 805 | 1.630 |
Why?
|
| Aortic Aneurysm | 3 | 2020 | 233 | 1.510 |
Why?
|
| Aortic Valve Stenosis | 8 | 2022 | 338 | 1.500 |
Why?
|
| Heart-Assist Devices | 5 | 2024 | 1027 | 1.340 |
Why?
|
| Surgeons | 3 | 2023 | 257 | 1.290 |
Why?
|
| Treatment Outcome | 37 | 2023 | 12287 | 1.120 |
Why?
|
| Endocarditis | 2 | 2021 | 106 | 1.110 |
Why?
|
| Aortic Valve Insufficiency | 3 | 2021 | 147 | 1.110 |
Why?
|
| Aortic Aneurysm, Thoracic | 5 | 2019 | 662 | 1.090 |
Why?
|
| Heart Failure | 8 | 2024 | 2299 | 1.070 |
Why?
|
| Prosthesis Failure | 2 | 2017 | 156 | 1.010 |
Why?
|
| Heart Ventricles | 8 | 2022 | 783 | 1.010 |
Why?
|
| Machine Learning | 4 | 2024 | 251 | 0.990 |
Why?
|
| Ventricular Remodeling | 3 | 2022 | 184 | 0.990 |
Why?
|
| Risk Assessment | 15 | 2022 | 3431 | 0.990 |
Why?
|
| Aged | 43 | 2024 | 19722 | 0.980 |
Why?
|
| Transcatheter Aortic Valve Replacement | 5 | 2022 | 199 | 0.950 |
Why?
|
| Humans | 90 | 2024 | 125362 | 0.930 |
Why?
|
| Hypersensitivity | 2 | 2017 | 185 | 0.920 |
Why?
|
| Heart Transplantation | 2 | 2021 | 859 | 0.910 |
Why?
|
| Risk Factors | 28 | 2022 | 10298 | 0.900 |
Why?
|
| Thoracic Surgery | 3 | 2022 | 161 | 0.900 |
Why?
|
| Mitral Valve Insufficiency | 5 | 2022 | 164 | 0.880 |
Why?
|
| Length of Stay | 5 | 2024 | 1310 | 0.810 |
Why?
|
| Anticoagulants | 5 | 2023 | 578 | 0.760 |
Why?
|
| Middle Aged | 37 | 2024 | 26763 | 0.750 |
Why?
|
| Retrospective Studies | 29 | 2024 | 16369 | 0.740 |
Why?
|
| Health Care Costs | 4 | 2017 | 372 | 0.740 |
Why?
|
| Patient Discharge | 3 | 2024 | 495 | 0.730 |
Why?
|
| Percutaneous Coronary Intervention | 2 | 2022 | 254 | 0.720 |
Why?
|
| Coronary Vessels | 3 | 2021 | 531 | 0.710 |
Why?
|
| Myocardial Revascularization | 2 | 2021 | 103 | 0.710 |
Why?
|
| Hospital Costs | 4 | 2017 | 179 | 0.690 |
Why?
|
| Pericardial Window Techniques | 1 | 2020 | 5 | 0.680 |
Why?
|
| Time Factors | 19 | 2024 | 6311 | 0.670 |
Why?
|
| Endocarditis, Bacterial | 1 | 2021 | 136 | 0.670 |
Why?
|
| Hernia, Abdominal | 1 | 2020 | 19 | 0.670 |
Why?
|
| Aftercare | 2 | 2021 | 147 | 0.660 |
Why?
|
| Pericardial Effusion | 1 | 2020 | 63 | 0.650 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2020 | 86 | 0.650 |
Why?
|
| Male | 54 | 2024 | 61566 | 0.650 |
Why?
|
| Hospitals | 2 | 2022 | 399 | 0.650 |
Why?
|
| Costs and Cost Analysis | 3 | 2018 | 163 | 0.640 |
Why?
|
| Blood Vessel Prosthesis Implantation | 3 | 2017 | 763 | 0.640 |
Why?
|
| Endothelial Progenitor Cells | 1 | 2019 | 10 | 0.640 |
Why?
|
| Sternotomy | 2 | 2019 | 42 | 0.620 |
Why?
|
| Virginia | 7 | 2017 | 20 | 0.620 |
Why?
|
| Quality of Life | 3 | 2016 | 1909 | 0.620 |
Why?
|
| Extracellular Vesicles | 1 | 2019 | 46 | 0.610 |
Why?
|
| Ticks | 1 | 2018 | 30 | 0.610 |
Why?
|
| Consumer Health Information | 1 | 2018 | 24 | 0.600 |
Why?
|
| Dependovirus | 1 | 2019 | 128 | 0.600 |
Why?
|
| Secondary Prevention | 1 | 2020 | 216 | 0.600 |
Why?
|
| Mortality | 2 | 2017 | 238 | 0.600 |
Why?
|
| Stroke | 3 | 2024 | 983 | 0.600 |
Why?
|
| Female | 51 | 2024 | 66821 | 0.580 |
Why?
|
| Methylene Blue | 1 | 2017 | 13 | 0.550 |
Why?
|
| Internship and Residency | 4 | 2021 | 1183 | 0.550 |
Why?
|
| Educational Measurement | 1 | 2020 | 323 | 0.550 |
Why?
|
| Vasoplegia | 1 | 2017 | 11 | 0.550 |
Why?
|
| Survival Rate | 11 | 2020 | 2050 | 0.550 |
Why?
|
| Troponin I | 1 | 2018 | 108 | 0.540 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2018 | 149 | 0.540 |
Why?
|
| Quality Indicators, Health Care | 2 | 2018 | 218 | 0.540 |
Why?
|
| Aortic Aneurysm, Abdominal | 2 | 2019 | 424 | 0.540 |
Why?
|
| Hospital Mortality | 11 | 2022 | 1027 | 0.540 |
Why?
|
| Quality Assurance, Health Care | 1 | 2018 | 207 | 0.530 |
Why?
|
| Heart Valve Diseases | 2 | 2016 | 174 | 0.530 |
Why?
|
| Lung Transplantation | 1 | 2020 | 323 | 0.530 |
Why?
|
| Disaccharides | 1 | 2016 | 14 | 0.520 |
Why?
|
| Surgical Procedures, Operative | 1 | 2018 | 184 | 0.520 |
Why?
|
| Acute Kidney Injury | 3 | 2022 | 649 | 0.510 |
Why?
|
| Palliative Care | 1 | 2020 | 433 | 0.500 |
Why?
|
| Prosthesis Design | 5 | 2023 | 668 | 0.500 |
Why?
|
| Propensity Score | 4 | 2024 | 222 | 0.500 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 1 | 2016 | 40 | 0.500 |
Why?
|
| Erythropoietin | 1 | 2016 | 106 | 0.480 |
Why?
|
| Postoperative Care | 1 | 2017 | 301 | 0.470 |
Why?
|
| Calcium | 1 | 2019 | 1105 | 0.460 |
Why?
|
| Proportional Hazards Models | 6 | 2018 | 1362 | 0.460 |
Why?
|
| United States | 13 | 2024 | 10909 | 0.450 |
Why?
|
| Thoracotomy | 1 | 2015 | 110 | 0.440 |
Why?
|
| Marfan Syndrome | 1 | 2016 | 143 | 0.440 |
Why?
|
| Databases, Factual | 7 | 2021 | 1172 | 0.430 |
Why?
|
| Patient Selection | 5 | 2020 | 696 | 0.400 |
Why?
|
| Thrombosis | 1 | 2017 | 524 | 0.400 |
Why?
|
| Kaplan-Meier Estimate | 5 | 2020 | 1065 | 0.400 |
Why?
|
| Atherosclerosis | 1 | 2019 | 910 | 0.370 |
Why?
|
| Reoperation | 4 | 2020 | 830 | 0.370 |
Why?
|
| Aorta, Thoracic | 2 | 2015 | 526 | 0.370 |
Why?
|
| Myocardium | 3 | 2022 | 1022 | 0.360 |
Why?
|
| Endovascular Procedures | 2 | 2017 | 726 | 0.350 |
Why?
|
| Linear Models | 3 | 2017 | 683 | 0.350 |
Why?
|
| Tricuspid Valve | 2 | 2009 | 61 | 0.340 |
Why?
|
| Recovery of Function | 3 | 2023 | 433 | 0.330 |
Why?
|
| Leiomyosarcoma | 1 | 2009 | 28 | 0.320 |
Why?
|
| Incidence | 7 | 2020 | 3134 | 0.320 |
Why?
|
| Aged, 80 and over | 11 | 2016 | 6558 | 0.320 |
Why?
|
| Heart Arrest, Induced | 3 | 2020 | 75 | 0.310 |
Why?
|
| Follow-Up Studies | 8 | 2020 | 5171 | 0.300 |
Why?
|
| Myocardial Ischemia | 1 | 2011 | 345 | 0.290 |
Why?
|
| Minimally Invasive Surgical Procedures | 3 | 2021 | 195 | 0.290 |
Why?
|
| Cerebral Revascularization | 1 | 2007 | 21 | 0.280 |
Why?
|
| Observer Variation | 2 | 2018 | 300 | 0.280 |
Why?
|
| Survivors | 1 | 2009 | 339 | 0.270 |
Why?
|
| Hemorrhage | 2 | 2013 | 467 | 0.270 |
Why?
|
| Coronary Aneurysm | 1 | 2007 | 33 | 0.270 |
Why?
|
| Cardiac Catheterization | 3 | 2016 | 633 | 0.260 |
Why?
|
| Logistic Models | 4 | 2018 | 1802 | 0.260 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2006 | 63 | 0.260 |
Why?
|
| Preoperative Care | 3 | 2018 | 353 | 0.250 |
Why?
|
| Comorbidity | 4 | 2022 | 1528 | 0.250 |
Why?
|
| Age Factors | 5 | 2018 | 2818 | 0.240 |
Why?
|
| Obesity | 1 | 2017 | 2252 | 0.240 |
Why?
|
| Prognosis | 5 | 2020 | 4686 | 0.240 |
Why?
|
| Neoplasms | 1 | 2020 | 2799 | 0.240 |
Why?
|
| Heart | 2 | 2020 | 731 | 0.240 |
Why?
|
| Surgical Wound Infection | 2 | 2017 | 259 | 0.240 |
Why?
|
| Aorta | 3 | 2018 | 545 | 0.230 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2005 | 77 | 0.230 |
Why?
|
| Animals | 14 | 2022 | 34319 | 0.230 |
Why?
|
| Stomach Ulcer | 1 | 2005 | 94 | 0.230 |
Why?
|
| Adult | 12 | 2021 | 29543 | 0.230 |
Why?
|
| Gastrostomy | 1 | 2005 | 87 | 0.220 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2021 | 617 | 0.220 |
Why?
|
| Catheterization | 2 | 2018 | 227 | 0.220 |
Why?
|
| Rats | 2 | 2021 | 3729 | 0.220 |
Why?
|
| Sheep | 6 | 2012 | 220 | 0.220 |
Why?
|
| Motion | 1 | 2023 | 43 | 0.210 |
Why?
|
| Clinical Competence | 2 | 2023 | 1001 | 0.210 |
Why?
|
| Survival Analysis | 2 | 2018 | 1495 | 0.210 |
Why?
|
| Multiple Pulmonary Nodules | 1 | 2023 | 19 | 0.210 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2023 | 24 | 0.210 |
Why?
|
| Chi-Square Distribution | 2 | 2015 | 586 | 0.200 |
Why?
|
| MicroRNAs | 2 | 2022 | 855 | 0.200 |
Why?
|
| Anastomosis, Surgical | 1 | 2023 | 165 | 0.200 |
Why?
|
| Hand | 1 | 2023 | 100 | 0.200 |
Why?
|
| Enteral Nutrition | 1 | 2005 | 259 | 0.200 |
Why?
|
| Alveolar Bone Loss | 1 | 2022 | 2 | 0.200 |
Why?
|
| Atrial Appendage | 1 | 2022 | 47 | 0.200 |
Why?
|
| Periodontitis | 1 | 2022 | 11 | 0.200 |
Why?
|
| Cardiopulmonary Bypass | 2 | 2018 | 354 | 0.190 |
Why?
|
| Registries | 3 | 2020 | 1434 | 0.190 |
Why?
|
| Severity of Illness Index | 5 | 2018 | 2909 | 0.190 |
Why?
|
| Biocompatible Materials | 1 | 2022 | 117 | 0.190 |
Why?
|
| Cardioplegic Solutions | 2 | 2020 | 17 | 0.190 |
Why?
|
| Dietary Supplements | 1 | 2005 | 472 | 0.190 |
Why?
|
| Gastric Mucosa | 1 | 2005 | 488 | 0.180 |
Why?
|
| Mesothelioma | 1 | 2022 | 88 | 0.180 |
Why?
|
| Anterior Wall Myocardial Infarction | 1 | 2021 | 11 | 0.180 |
Why?
|
| Monitoring, Intraoperative | 1 | 2021 | 133 | 0.180 |
Why?
|
| Alginates | 1 | 2020 | 19 | 0.180 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2009 | 933 | 0.180 |
Why?
|
| Biomarkers | 3 | 2019 | 3106 | 0.180 |
Why?
|
| Prosthesis Implantation | 2 | 2020 | 140 | 0.170 |
Why?
|
| Organ Preservation | 1 | 2020 | 45 | 0.170 |
Why?
|
| Preoperative Period | 2 | 2017 | 88 | 0.170 |
Why?
|
| Embolectomy | 1 | 2020 | 7 | 0.170 |
Why?
|
| Blood Loss, Surgical | 2 | 2018 | 153 | 0.170 |
Why?
|
| Hydrogels | 1 | 2021 | 84 | 0.170 |
Why?
|
| Hemodynamics | 3 | 2020 | 849 | 0.170 |
Why?
|
| Algorithms | 3 | 2021 | 1633 | 0.160 |
Why?
|
| Perfusion | 1 | 2020 | 206 | 0.160 |
Why?
|
| Mitochondria | 1 | 2024 | 680 | 0.160 |
Why?
|
| Shock, Cardiogenic | 1 | 2021 | 193 | 0.160 |
Why?
|
| Thorax | 1 | 2019 | 73 | 0.160 |
Why?
|
| Aorta, Abdominal | 1 | 2020 | 122 | 0.160 |
Why?
|
| Polyethylene Glycols | 1 | 2021 | 240 | 0.160 |
Why?
|
| Liver Neoplasms | 1 | 2009 | 1316 | 0.160 |
Why?
|
| Odds Ratio | 3 | 2017 | 1253 | 0.160 |
Why?
|
| Cohort Studies | 6 | 2020 | 4828 | 0.150 |
Why?
|
| Postoperative Period | 3 | 2020 | 335 | 0.150 |
Why?
|
| Medicare | 1 | 2022 | 427 | 0.150 |
Why?
|
| Frailty | 1 | 2021 | 105 | 0.150 |
Why?
|
| ST Elevation Myocardial Infarction | 1 | 2021 | 113 | 0.150 |
Why?
|
| Access to Information | 1 | 2018 | 40 | 0.150 |
Why?
|
| Thrombolytic Therapy | 1 | 2020 | 200 | 0.150 |
Why?
|
| Cell Survival | 1 | 2021 | 821 | 0.150 |
Why?
|
| Health Communication | 1 | 2018 | 27 | 0.150 |
Why?
|
| Liver Cirrhosis | 1 | 2005 | 859 | 0.150 |
Why?
|
| Cost Savings | 2 | 2017 | 71 | 0.150 |
Why?
|
| Sex Factors | 3 | 2018 | 1275 | 0.150 |
Why?
|
| Mediastinitis | 1 | 2017 | 14 | 0.150 |
Why?
|
| Wearable Electronic Devices | 1 | 2019 | 103 | 0.140 |
Why?
|
| Acute Disease | 2 | 2020 | 1097 | 0.140 |
Why?
|
| Hyperglycemia | 2 | 2017 | 227 | 0.140 |
Why?
|
| Atrial Fibrillation | 2 | 2022 | 657 | 0.140 |
Why?
|
| Pulmonary Embolism | 1 | 2020 | 173 | 0.140 |
Why?
|
| Thromboembolism | 1 | 2018 | 89 | 0.140 |
Why?
|
| Meat | 1 | 2017 | 48 | 0.140 |
Why?
|
| Transfection | 1 | 2019 | 1076 | 0.140 |
Why?
|
| Multilevel Analysis | 1 | 2017 | 8 | 0.140 |
Why?
|
| Perception | 1 | 2018 | 220 | 0.140 |
Why?
|
| Echocardiography | 4 | 2016 | 1067 | 0.130 |
Why?
|
| Career Choice | 1 | 2018 | 148 | 0.130 |
Why?
|
| Emergencies | 1 | 2018 | 172 | 0.130 |
Why?
|
| Lung | 2 | 2023 | 1491 | 0.130 |
Why?
|
| Learning Curve | 1 | 2017 | 53 | 0.130 |
Why?
|
| Respiration, Artificial | 2 | 2021 | 473 | 0.130 |
Why?
|
| Psoas Muscles | 1 | 2016 | 5 | 0.130 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2017 | 118 | 0.130 |
Why?
|
| Walk Test | 1 | 2016 | 24 | 0.130 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2023 | 2096 | 0.130 |
Why?
|
| Perioperative Care | 1 | 2018 | 195 | 0.130 |
Why?
|
| Tomography | 2 | 2009 | 41 | 0.130 |
Why?
|
| Disease Progression | 2 | 2015 | 2084 | 0.120 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 880 | 0.120 |
Why?
|
| Sarcopenia | 1 | 2016 | 42 | 0.120 |
Why?
|
| Vascular Remodeling | 1 | 2015 | 40 | 0.120 |
Why?
|
| Nitric Oxide | 1 | 2018 | 485 | 0.120 |
Why?
|
| Genetic Therapy | 1 | 2019 | 688 | 0.120 |
Why?
|
| Blood Vessel Prosthesis | 2 | 2017 | 521 | 0.120 |
Why?
|
| Hypoglycemia | 1 | 2016 | 192 | 0.120 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 2880 | 0.110 |
Why?
|
| Obesity, Morbid | 1 | 2017 | 186 | 0.110 |
Why?
|
| Cost of Illness | 1 | 2016 | 252 | 0.110 |
Why?
|
| Enzyme Inhibitors | 1 | 2017 | 587 | 0.110 |
Why?
|
| Cause of Death | 1 | 2016 | 473 | 0.110 |
Why?
|
| Clostridium Infections | 1 | 2017 | 245 | 0.110 |
Why?
|
| Overweight | 1 | 2017 | 363 | 0.110 |
Why?
|
| Chronic Disease | 2 | 2015 | 1189 | 0.110 |
Why?
|
| Radial Artery | 1 | 2013 | 28 | 0.110 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 1654 | 0.100 |
Why?
|
| Stents | 2 | 2017 | 835 | 0.100 |
Why?
|
| Blood Transfusion | 1 | 2015 | 311 | 0.100 |
Why?
|
| Quality Improvement | 2 | 2019 | 648 | 0.100 |
Why?
|
| Inflammation | 1 | 2019 | 1445 | 0.100 |
Why?
|
| Hepatopulmonary Syndrome | 1 | 2011 | 8 | 0.090 |
Why?
|
| Heart Function Tests | 2 | 2012 | 58 | 0.090 |
Why?
|
| Massachusetts | 1 | 2011 | 125 | 0.090 |
Why?
|
| Ligation | 2 | 2012 | 133 | 0.090 |
Why?
|
| Prostheses and Implants | 1 | 2012 | 153 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 1269 | 0.090 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2017 | 732 | 0.090 |
Why?
|
| End Stage Liver Disease | 1 | 2013 | 182 | 0.090 |
Why?
|
| Liver | 2 | 2009 | 1749 | 0.090 |
Why?
|
| Hypertension, Portal | 1 | 2011 | 78 | 0.090 |
Why?
|
| Elective Surgical Procedures | 1 | 2011 | 158 | 0.090 |
Why?
|
| Heart Arrest | 1 | 2014 | 356 | 0.080 |
Why?
|
| Heart Valves | 1 | 2009 | 51 | 0.080 |
Why?
|
| Radiography, Abdominal | 1 | 2009 | 48 | 0.080 |
Why?
|
| Histocytochemistry | 1 | 2009 | 100 | 0.080 |
Why?
|
| Capsule Endoscopy | 1 | 2009 | 20 | 0.080 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2008 | 248 | 0.080 |
Why?
|
| Feasibility Studies | 2 | 2008 | 762 | 0.080 |
Why?
|
| Societies, Medical | 1 | 2013 | 700 | 0.080 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2009 | 42 | 0.080 |
Why?
|
| Microscopy | 1 | 2009 | 119 | 0.080 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2008 | 88 | 0.080 |
Why?
|
| Hospitalization | 1 | 2017 | 1791 | 0.070 |
Why?
|
| Hypertension | 1 | 2017 | 1332 | 0.070 |
Why?
|
| Cardiac Output | 1 | 2008 | 170 | 0.070 |
Why?
|
| ROC Curve | 1 | 2009 | 572 | 0.070 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2008 | 145 | 0.070 |
Why?
|
| Hyperkalemia | 1 | 2008 | 67 | 0.070 |
Why?
|
| Liver Diseases | 1 | 2011 | 368 | 0.070 |
Why?
|
| Time | 1 | 2007 | 92 | 0.070 |
Why?
|
| Sugar Alcohols | 1 | 2006 | 3 | 0.070 |
Why?
|
| Parenteral Nutrition, Home | 1 | 2006 | 7 | 0.070 |
Why?
|
| Models, Animal | 1 | 2008 | 456 | 0.070 |
Why?
|
| Liver Transplantation | 2 | 2013 | 1042 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 3176 | 0.060 |
Why?
|
| Operative Time | 2 | 2017 | 165 | 0.060 |
Why?
|
| Sutures | 1 | 2006 | 64 | 0.060 |
Why?
|
| Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2006 | 18 | 0.060 |
Why?
|
| Rifamycins | 1 | 2006 | 21 | 0.060 |
Why?
|
| Aspartate Aminotransferases | 1 | 2006 | 85 | 0.060 |
Why?
|
| Alkaline Phosphatase | 1 | 2006 | 99 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2017 | 2430 | 0.060 |
Why?
|
| Liver Failure | 1 | 2006 | 89 | 0.060 |
Why?
|
| Hepatic Encephalopathy | 1 | 2006 | 79 | 0.060 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2008 | 374 | 0.060 |
Why?
|
| Decision Support Techniques | 2 | 2020 | 290 | 0.060 |
Why?
|
| Cartilage, Articular | 1 | 2005 | 57 | 0.060 |
Why?
|
| Oxidative Phosphorylation | 1 | 2024 | 107 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2009 | 1902 | 0.050 |
Why?
|
| Disease Models, Animal | 3 | 2012 | 4409 | 0.050 |
Why?
|
| Coronary Disease | 1 | 2007 | 675 | 0.050 |
Why?
|
| Ventricular Function, Left | 1 | 2007 | 514 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2007 | 1320 | 0.050 |
Why?
|
| Recurrence | 1 | 2006 | 1394 | 0.050 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2005 | 128 | 0.050 |
Why?
|
| Porphyromonas gingivalis | 1 | 2022 | 1 | 0.050 |
Why?
|
| Treponema denticola | 1 | 2022 | 2 | 0.050 |
Why?
|
| Interleukin-2 | 1 | 2022 | 244 | 0.050 |
Why?
|
| Mediastinum | 1 | 2022 | 43 | 0.050 |
Why?
|
| Young Adult | 1 | 2016 | 9061 | 0.050 |
Why?
|
| Osteoarthritis, Knee | 1 | 2005 | 244 | 0.050 |
Why?
|
| B7-H1 Antigen | 1 | 2022 | 120 | 0.050 |
Why?
|
| Ophthalmoscopes | 1 | 2001 | 4 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2007 | 1377 | 0.050 |
Why?
|
| Research Design | 1 | 2005 | 693 | 0.050 |
Why?
|
| Ophthalmoscopy | 1 | 2001 | 28 | 0.050 |
Why?
|
| Wrist | 1 | 2021 | 24 | 0.050 |
Why?
|
| Accreditation | 1 | 2021 | 88 | 0.050 |
Why?
|
| Creatinine | 1 | 2022 | 394 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2022 | 372 | 0.040 |
Why?
|
| Geriatric Assessment | 1 | 2021 | 175 | 0.040 |
Why?
|
| Tomography, Optical Coherence | 1 | 2005 | 527 | 0.040 |
Why?
|
| Prospective Studies | 3 | 2017 | 6141 | 0.040 |
Why?
|
| Accidental Falls | 1 | 2021 | 104 | 0.040 |
Why?
|
| Fear | 1 | 2021 | 199 | 0.040 |
Why?
|
| Early Detection of Cancer | 1 | 2023 | 362 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2019 | 134 | 0.040 |
Why?
|
| Ventricular Function, Right | 1 | 2020 | 113 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2011 | 1961 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2020 | 263 | 0.040 |
Why?
|
| Adolescent | 1 | 2016 | 19430 | 0.040 |
Why?
|
| Direct Service Costs | 1 | 2017 | 8 | 0.040 |
Why?
|
| Walking | 1 | 2019 | 216 | 0.040 |
Why?
|
| Activities of Daily Living | 1 | 2019 | 394 | 0.030 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2021 | 459 | 0.030 |
Why?
|
| Cytokines | 1 | 2022 | 1291 | 0.030 |
Why?
|
| Canada | 1 | 2017 | 286 | 0.030 |
Why?
|
| Education, Medical, Graduate | 1 | 2021 | 522 | 0.030 |
Why?
|
| Benchmarking | 1 | 2017 | 137 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2019 | 510 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2017 | 404 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2017 | 730 | 0.030 |
Why?
|
| Mice | 2 | 2022 | 17750 | 0.030 |
Why?
|
| Frail Elderly | 1 | 2016 | 95 | 0.030 |
Why?
|
| Organ Size | 1 | 2016 | 442 | 0.030 |
Why?
|
| Morbidity | 1 | 2015 | 248 | 0.030 |
Why?
|
| Operating Rooms | 1 | 2015 | 69 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2017 | 511 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2017 | 779 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2015 | 440 | 0.030 |
Why?
|
| Punctures | 1 | 2013 | 55 | 0.030 |
Why?
|
| Heart Diseases | 1 | 2017 | 496 | 0.030 |
Why?
|
| Cardiac Tamponade | 1 | 2012 | 36 | 0.020 |
Why?
|
| Sheep, Domestic | 1 | 2012 | 17 | 0.020 |
Why?
|
| Computational Biology | 1 | 2017 | 819 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2016 | 1134 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2012 | 95 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2015 | 543 | 0.020 |
Why?
|
| Waiting Lists | 1 | 2013 | 227 | 0.020 |
Why?
|
| Patient Care Team | 1 | 2015 | 543 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2013 | 449 | 0.020 |
Why?
|
| Transcriptome | 1 | 2017 | 977 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 1756 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2017 | 3313 | 0.020 |
Why?
|
| HIV | 1 | 2011 | 181 | 0.020 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2012 | 313 | 0.020 |
Why?
|
| Heart Septum | 1 | 2008 | 54 | 0.020 |
Why?
|
| Patient Safety | 1 | 2013 | 398 | 0.020 |
Why?
|
| Surgical Instruments | 1 | 2008 | 54 | 0.020 |
Why?
|
| Diastole | 1 | 2008 | 178 | 0.020 |
Why?
|
| Suture Techniques | 1 | 2008 | 193 | 0.020 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2007 | 112 | 0.020 |
Why?
|
| Fatty Acids, Essential | 1 | 2006 | 6 | 0.020 |
Why?
|
| Liver Function Tests | 1 | 2006 | 100 | 0.020 |
Why?
|
| Nutritional Requirements | 1 | 2006 | 181 | 0.010 |
Why?
|
| Birefringence | 1 | 2005 | 11 | 0.010 |
Why?
|
| Swine | 1 | 2008 | 1179 | 0.010 |
Why?
|
| Intraoperative Period | 1 | 2005 | 73 | 0.010 |
Why?
|
| Computer Systems | 1 | 2005 | 37 | 0.010 |
Why?
|
| Collagen | 1 | 2005 | 317 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2005 | 585 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2006 | 1118 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 3605 | 0.010 |
Why?
|
| Macula Lutea | 1 | 2001 | 47 | 0.010 |
Why?
|
| Optics and Photonics | 1 | 2001 | 139 | 0.010 |
Why?
|
| Eye Diseases | 1 | 2001 | 117 | 0.010 |
Why?
|
| Equipment Design | 1 | 2001 | 589 | 0.010 |
Why?
|
| Retina | 1 | 2001 | 452 | 0.010 |
Why?
|
| Cornea | 1 | 2001 | 658 | 0.010 |
Why?
|